Two speakers, one message: don’t pay for the hype — pay for what’s mispriced. UTI’s June equity webinar argues the same discipline from opposite ends of the risk spectrum, with large-cap quality-growth on one side and high-optionality innovation on the other.
US AI CONCENTRATION
INDIA LARGE CAPS
SMALL & MID CAPS
RUPEE
Summary
On paper, UTI’s June equity webinar had two unrelated halves — Vetri Subramanyam on the macro-outlook, Nitan Jain on the UTI Innovation Fund. In substance, both argue the same thing from opposite ends of the risk spectrum: ignore the crowded narrative, look for what the market has mispriced. The macro half flags AI concentration in the US and crowded small- and mid-caps in India, while pointing to large-cap quality-growth as the better-positioned corner. The innovation half makes the same case in higher-risk form — owning businesses where the market pays for today’s engine and ignores the next one. Valuations and optionality are two faces of the same discipline: mispricing over narrative.
The detail
The macro half — concentration is the signal
UTI flags that AI-linked names are now around 40% of the US market — concentration that, in past cycles, has tended to precede sharp reversals. They call it a “blinking orange” signal, not a timing tool.
India is the mirror image: the crowd sits in expensive small- and mid-caps, while large-caps have entered the zone UTI’s own valuation indicator links to raising equity allocation — historically followed by positive one-year returns about 93% of the time.
A rupee that now screens as undervalued caps the currency risk that usually drives foreign selling. The read: the crowded trades carry more risk than reward, and large-cap quality-growth is the better-positioned corner.
The innovation half — same discipline, higher risk
The UTI Innovation Fund is easy to mistake for an AI bet. The real thesis is optionality — owning businesses where the market pays for today’s engine and ignores the next one.
UTI’s example: Eternal (formerly Zomato). At listing, the quick-commerce arm was given negative value; today, on UTI’s reading, it’s worth more per share than food delivery itself.
It’s bought with discipline — about 27 stocks from a 65–70 name universe, 96% active share (how far a fund strays from its benchmark) — so it’s bottom-up, not an index in disguise.
The honest caveat on innovation
UTI is upfront about the risk profile of the Innovation Fund: early-stage, often loss-making businesses, large NAV swings, and only sensible for a 10-year-plus horizon.
Optionality cuts both ways. The thesis only works when investors can sit through volatility long enough for the second engine to be priced in by the market.
The throughline
Valuations and optionality are two faces of the same discipline: mispricing over narrative.
The part of the market most crowded into a story is rarely the part best-positioned from here. Whether the call is “rotate from small-mid to large-cap” or “own the second engine the market hasn’t priced,” the underlying instruction is the same.
What this means for investors
The takeaway
Respond to mispricing, not headlines — at both ends of your portfolio:
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully. The views expressed are those of the speakers and do not constitute investment advice.
